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Original articleClic4, a novel protein that sensitizes b-cells
to apoptosisaDhaval Patel 1, Damien Ythier 1, Flora Brozzi 2, Decio L. Eizirik 2, Bernard Thorens 1,*ABSTRACT
Objectives: Chloride intracellular channel protein 4 (Clic4) is a ubiquitously expressed protein involved in multiple cellular processes including
cell-cycle control, cell differentiation, and apoptosis. Here, we investigated the role of Clic4 in pancreatic b-cell apoptosis.
Methods: We used bTC-tet cells and islets from b-cell speciﬁc Clic4 knockout mice (bClic4KO) and assessed cytokine-induced apoptosis, Bcl2
family protein expression and stability, and identiﬁed Clic4-interacting proteins by co-immunoprecipitation and mass spectrometry analysis.
Results: We show that cytokines increased Clic4 expression in bTC-tet cells and in mouse islets and siRNA-mediated silencing of Clic4
expression in bTC-tet cells or its genetic inactivation in islets b-cells, reduced cytokine-induced apoptosis. This was associated with increased
expression of Bcl-2 and increased expression and phosphorylation of Bad. Measurement of Bcl-2 and Bad half-lives in bTC-tet cells showed that
Clic4 silencing increased the stability of these proteins. In primary islets b-cells, absence of Clic4 expression increased Bcl-2 and Bcl-xL
expression as well as expression and phosphorylation of Bad. Mass-spectrometry analysis of proteins co-immunoprecipitated with Clic4 from
bTC-tet cells showed no association of Clic4 with Bcl-2 family proteins. However, Clic4 co-puriﬁed with proteins from the proteasome suggesting
a possible role for Clic4 in regulating protein degradation.
Conclusions: Collectively, our data show that Clic4 is a cytokine-induced gene that sensitizes b-cells to apoptosis by reducing the steady state
levels of Bcl-2, Bad and phosphorylated Bad.
 2015 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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A complete destruction of pancreatic b-cells, caused by an autoim-
mune reaction, underlies the development of type 1 diabetes [1]. In
type 2 diabetes, a partial reduction in b-cell mass is also observed and
may contribute to the impaired capacity of the endocrine pancreas to
secrete enough insulin to compensate for the development of insulin
resistance in peripheral tissues [2]. The destruction of b-cells in Type 1
diabetes is mediated by pro-inﬂammatory cytokines, such as IL-1b,
IFN-g and TNF-a [1,3], and by other pro-apoptotic mediators provided
by activated immune cells, such as FasL and perforins/granzymes
[4,5]. In type 2 diabetes, pancreatic islets also show signs of inﬂam-
mation with inﬁltrating macrophages [6] and increased production of
cytokines and chemokines by the islet cells themselves [7,8]. Evidence
for toxic effects of elevated glucose and saturated free fatty acid levels
(glucolipotoxicity) on b-cells is well established [9e13], and energy-
dense diets, rich in reﬁned sugars and saturated fats can contribute
to loss of functional b-cells through apoptosis. Cytokines (IL-1b, IFN-g
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www.molecularmetabolism.comreceptors and activation of NF-kB, STAT1 and JNK [14e16], leading to
activation of pro-apoptotic Bcl-2 family proteins [17]. These proteins
interact with anti-apoptotic Bcl-2 proteins through their Bcl-2 homol-
ogy 3 (BH3) domain in a hierarchical way [18]. The balance and
interaction between these proteins decides cell fate by activating or
inactivating pro-death proteins Bax and Bak [19,20], which then
triggers apoptosis following mitochondrial outer membrane per-
meabilization (MOMP) [21]. Saturated free fatty acids are thought to
induce apoptosis in large part through an initial activation of the ER
stress pathway [10] that leads to activation of protein kinase R-like ER
kinase (PERK), inositol requiring 1 (IRE1) and activating transcription
factor 6 (ATF6). However, this ultimately also converges on the acti-
vation of the pro-apoptotic Bcl2 family proteins that activate mito-
chondrial outer membrane permeabilization and caspase 3-dependent
apoptosis [22,23].
Because both forms of diabetes are associated with apoptosis-
dependent loss of b-cell mass, identifying novel proteins involved in
the control of apoptosis may lead to novel approaches to preserve b-
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Original articleClic4 (chloride intracellular channel 4) is a 28 kDa protein, which was
initially cloned from rat brain [24] and proposed to be a chloride
channel because of its homology to p64, a member of the chloride ion
channel family [24,25]; this proposed channel function, however, has
not been supported by more recent studies [26]. In contrast, Clic4 has
been implicated in regulating cell cycle arrest, cell differentiation, and
apoptosis, [27e31]. In keratinocytes, Clic4 is up-regulated by TNF-a
[32] and in p53- or c-myc-mediated apoptosis [33,34]. Clic4 is found
in the cytosol but under some conditions it may be associated with
mitochondria or the nucleus and increase apoptosis through cyto-
chrome c release from mitochondria and caspase-3 activation [32,35].
Here, we investigated the role of Clic4 in pancreatic b-cell apoptosis by
suppressing Clic4 expression in bTC-tet cells or by using islets from b-
cell speciﬁc conditional Clic4 knockout mice (bClic4KO). We showed
that siRNA-mediated Clic4 silencing in bTC-tet cells or its genetic
inactivation in islets b-cells reduces the sensitivity of these cells to
cytokines- or palmitic acid-induced apoptosis. Moreover, we show that
Clic4 knockdown reduces the degradation rate of Bcl-2 and Bad and
increases the total level of phosphorylated Bad, possibly as a result of
Clic4 interaction with the proteasome.
2. MATERIALS AND METHODS
2.1. Reagents
TNF-a and IL-1b were purchased from Calbiochem (Nyon,
Switzerland); IFN-g, palmitic acid, cycloheximide from Sigma (St.
Louis, MO); exendin-4 from Bachem AG (Bubendorf, Switzerland);
protease and phosphatase inhibitors were from Roche (Rotkreuz,
Switzerland); other reagents were of analytical or cell culture grade
purity.
2.2. Antibodies
Rabbit anti-actin and mouse anti-a-tubulin were from Sigma (St.
Louis, MO); rabbit antibodies to caspase-3, Bcl2, Bcl-xL, Bad,
phospho-Bad (ser-112) and Bax were from Cell signaling (Danvers,
MA, USA); rabbit antibodies to phospho-Bim (ser-69), Bim, Puma,
phospho-SAPK/JNK (Thr-183/Tyr-185), SAPK/JNK were from Cell
signaling. Secondary horseradish peroxidase (HRP) conjugated anti-
rabbit IgG (from donkey) and HRP conjugated anti-mouse IgG (from
sheep) were from GE healthcare (Nyon, Switzerland).
2.3. Cell culture
The mouse pancreatic bTC-tet cell line [36] were grown in Dulbecco’s
modiﬁed Eagle’s medium þ glutamax (Gibco, Zug, Switzerland),
supplemented with 15% horse serum, 2.5% fetal bovine serum,
10 mM HEPES, 1 mM sodium pyruvate at 37 C in a CO2 incubator and
used between passages 20 and 35.
Min6(B1) cells [37] were grown in Dulbecco’s modiﬁed Eagle’s
medium þ glutamax, supplemented with 15% heat-inactivated fetal
calf serum, 71 mM b-mercaptoethanol and used between passages 19
and 30.
2.4. Clic4 speciﬁc siRNA and reverse transfection
The Clic4 speciﬁc siRNA (siClic4) has the following sequence: CCG CAA
CTT TGA TAT TCC TAA AGG A (Invitrogen, Zug, Switzerland). Cells were
reverse transfected by diluting 150 nM of siClic4 or siCT (negative
control siRNA, Invitrogen, Zug, Switzerland) in serum free medium in a
tissue culture plate; 7.5 ml of Lipofectamine RNAiMax (Invitrogen, Zug,
Switzerland) was then added and incubated at room temperature for
20 min to form Lipid-siRNA complex. The complex was diluted to ﬁve
times with growth medium containing 1  106 bTC-tet cells to obtain254 MOLECULAR METABOLISM 4 (2015) 253e264  2015 The Authors. Published by Elsevier GmbH. Ta ﬁnal siRNA concentration of 30 nM. The transfected cells were
incubated at 37 C in a CO2 incubator (medium was replaced after
every 24 h) and were used for the experiments, 48 h after transfection.
2.5. Generation of b-cell speciﬁc Clic4 conditional knockout mice
Clic4 ﬂoxed mice were generated by homologous recombination in
embryonic stem cells using the strategy depicted in Figure 5A
(Genoway, Lyon, France). The neo cassette was removed by crossing
Clic4lox/þ mice with Flp-deleter mice. The neomycin negative male
Clic4lox/þ mice were then crossed with female Ins1Cre/þ mice [38] to
generate Clic4lox/þ; Ins1Cre/þ and Clic4lox/þ mice. Mice with homo-
zygous b-cell deletion of Clic4 were generated by crossing Clic4lox/þ;
Ins1Cre/þ mice with Clic4lox/þ mice in order to obtain Clic4lox/lox; Ins1
Cre/þ mice (bClic4KO) and control littermates (Control). Mice were on a
C57BL/6 background. All studies were performed with littermates.
Mice were housed on a 12-h light/dark cycle and fed a standard rodent
chow (Diet 3436; Provimi Kliba AG, Penthallaz, Switzerland).
2.6. Islets isolation and culture
Islets were isolated from 8 to 12-week-old mice as described in Ref.
[39] and, after handpicking, they were kept overnight in RPMI-1640
medium (Gibco, Zug, Switzerland), supplemented with 10% FBS,
2 mM Glutamax, 100 units/ml penicillin, and 100 mg/ml streptomycin.
Islets were then kept in suspension for western blot analysis or for
apoptosis and proliferation experiments. For other experiments (see
Section 2.7), 20 islets were plated on tissue culture dishes coated with
an extracellular matrix (ECM) derived from bovine corneal endothelial
cells (Novamed, Jerusalem, Israel) for 6e7 days to form monolayers,
before starting treatment.
2.7. Cell treatment
For apoptosis measurements, bTC-tet cells or pancreatic islets were
treated with cytokines (25 ng/ml TNF-a, 10 ng/ml IL-1b and 10 ng/ml
IFN-g) for 15 h, or treated with 100 nM exendin-4 for 24 h or 48 h, or
treated for 48 h with 1 mM palmitic acid (a stock solution containing
10 mM palmitic acid and 20% fatty acid-free bovine serum albumin
(BSA) was prepared by dissolving 34.8 mg sodium palmitate in 4 ml of
phosphate buffered saline (PBS) atw70 C, and adding 2.5 g of fatty
acid-free BSA dissolved in 8 ml of PBS, the ﬁnal volume was brought to
12.5 ml with PBS and stored in aliquots at 20 C).
2.8. Clic4 antibody generation
Clic4 C-terminal and N-terminal peptides (MALSMPLNGLKEEDKEPC
and CKEVEIAYSDVAKRLTK, respectively) were conjugated to keyhole
limpet hemocyanin and used to immunize New Zealand White rabbits.
Immunization consisted in one boost injection and repeated challenges
with 1 mg of peptides. The rabbits were killed after a total of ﬁve
injections for serum collection and speciﬁc antibodies were puriﬁed by
afﬁnity chromatography. Antibody production was made by Biotem
(Grenoble, France).
2.9. Gel electrophoresis and western blot
bTC-tet cells or mouse islets were washed twice with cold PBS and
lysed on ice for 20 min in a buffer containing 50 mM Tris, pH 7.5, 0.1%
SDS, 1% Nonidet P40, 150 mM NaCl, 5 mM EDTA, 0.5% sodium
deoxycholate, and protease and phosphatase inhibitors. Lysates were
sonicated for 15 s, centrifuged at 12,000 g for 10 min at 4 C and
supernatants were collected. The protein concentrations were deter-
mined by BCA assay (Thermo scientiﬁc, Erembodegem, Belgium) and
equal amounts of protein lysates were resolved by 12% SDS-PAGE and
transferred onto a nitrocellulose membrane. The membranes werehis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
www.molecularmetabolism.com
Figure 1: Clic4 is a cytokine-induced protein and its silencing protects against cytokine-induced apoptosis. bTC-tet cells (A,B) or primary mouse islets (C,D) were left untreated or
treated with cytokines (IL-1b, IFN-g, TNF-a) for 15 h and Clic4 expression was measured by western blot analysis (A,C) and quantitated by densitometry analysis (B,D). Data are
mean  SD, n ¼ 3 independent experiments. (EeH) bTC-tet cells were transfected with siCT or siClic4. 48 h later they were exposed to 100 nM exendin-4 (Ex4) or left untreated
for 9 h and then treated with cytokines for 15 h. The efﬁcacy of Clic4 silencing was tested by western blot analysis (E). Apoptosis was measured by TUNEL assay (F) or by western
blot analysis of cleaved caspase-3; (G) western blot, (H) quantitation by densitometry analysis. The data are means  SD from three independent experiments. *p < 0.05;
**p < 0.01; ***p < 0.001. bTC-tet cells (I) or Min6(B1) cells (J) were transfected with siCT or siClic4. 72 h later, they were exposed to either 2 or 20 mM glucose for 1 h in the
presence or absence of 100 nM exendin-4 (Ex-4). Insulin secretion is expressed as percent of total intracellular content. The data are the means  SD from three independent
experiments.
MOLECULAR METABOLISM 4 (2015) 253e264  2015 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
www.molecularmetabolism.com
255
Original articleincubated with the appropriate primary antibodies and revealed using
horseradish peroxidase-conjugated secondary antibodies and
enhanced chemiluminescence detection reagents (Advansta, CA, USA);
quantiﬁcation of the band density was performed by densitometric
analysis.
2.10. Apoptosis assay
Apoptotic cells were identiﬁed by TUNEL assay using In Situ Cell Death
Detection Kit, Fluorescein (Roche, Rotkreuz, Switzerland). Cell nuclei
were stained with 40,6-diamidino-2-phenylindole (DAPI). The signals
were visualized with a ﬂuorescence microscope Leica (Nidau,
Switzerland). Photomicrographs were captured under green (TUNEL
positive) and blue (DAPI positive) channels at 20 magniﬁcation and
merged using the Leica software. Each condition reported represents
>2500 cells (bTC-tet cells or islet cells) counted by randomized ﬁeld
selection. The apoptosis is reported as the percent of TUNEL positive
nuclei over the total number of nuclei stained by DAPI, as quantitated
by Image J software (http://rsbweb.nih.gov/ij/).Figure 2: Clic4 silencing increases Bcl-2 and Bad expression as well as Bad phosphorylati
Bad in bTC-tet cells transfected with siCT or siClic4 and treated 48 h later with or without c
to b-actin is shown in (BeG) as is the ratio of phosphorylated Bad (pBad) to total Bad
**p < 0.01.
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Total RNAwas extracted from islets andbTC-tet cells using RNeasy Plus
micro kit (Qiagen, Hombrechtikon, Switzerland) and RNeasy mini kit
(Qiagen, Hombrechtikon, Switzerland), respectively, and cDNAs were
synthesized using SuperScript II Reverse Transcriptase (Invitrogen,
Zug, Switzerland) according to the manufacturer’s instructions.
Expression of target genes was measured by real time quantitative PCR
(qRT-PCR) using 7500 Fast Real-Time PCR System (Applied Bio-
systems; Zug, Switzerland) in a ﬁnal volume of 10 ml containing 2 ml of
cDNA and 5 ml of power SYBR Green PCR mix (Applied Biosystems; Zug,
Switzerland), in the presence of forward and reverse primers. Expres-
sion valueswere normalized to the expression of the housekeeping gene
TATA-box binding protein (TBP). Primer sequences are: for Bcl-2 (F) 50-
GATGACTGAGTACCTGAACCG-30, (R) 50-CAGAGACAGCCAGGAGAAATC-
30; for Bcl-xL (F) 50-GGAAAGCGTAGACAAGGAGATG-30, (R) 50-
GCATTGTTCCCGTAGAGATCC-30; for Bad (F) 50-AGGATGAGCGAT-
GAGTTTGAG-30, (R) 50-CCTTTGCCCAAGTTTCGATC-30; for Clic4 (F) 50-
GACAAAGAGCCCCTCATCGA-30, (R) 50-GTTTCCAATGCTTTCACCATC-30;on. (A) Western blot analysis of the indicated proteins and of the phosphorylated form of
ytokines for an additional 15 h period. Densitometry analysis of the proteins normalized
(D). The data are the means  SD from three independent experiments. *p < 0.05;
his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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TBP (F) 50-ATCCCAAGCGATTTGCTGC-30, (R) 50-ACTCTTGGCTCCTGTG-
CACA-30. All the primers were obtained from Microsynth (Balgach,
Switzerland).
2.12. Immunoprecipitation and LCeMS/MS analysis
bTC-tet cells were lysed in the immunoprecipitation buffer (20 mM
Tris, pH-7.4, 100 mM NaCl, 0.5% NP40 containing protease and
phosphatase inhibitors). One mg of cell lysate proteins was incubated
overnight with 7 mg of anti-Clic4 C-terminus, anti-Clic4 N-terminus, or
rabbit IgGs at 4 C with gentle rocking. After centrifugation at
13,000 rpm for 10 min at 4 C the supernatants were collected and
added on Protein G-Agarose beads (Roche, Rotkreuz, Switzerland),
incubated for 2 h at 4 C with gentle rocking and washed four times
with the immunoprecipitation buffer. After washing, beads were
heated in sample buffer (75 mM Tris, pH-6.8, 5% b-mercaptoethanol,
10% glycerol, 2.5% SDS) for 5 min at 95 C and used for western
blotting or mass-spectrometric (MS) analysis.
For mass-spectrometric analysis, immunoprecipitates were fraction-
ated by electrophoresis on a polyacrylamide gel and stained withFigure 3: Clic4 silencing did not affect expression of PUMA, Bims, BimL, BimEL or the phos
48 h, cells were left untreated or treated with cytokines for 15 h and expression of the indi
expression normalized to b-actin is shown in (BeG). The data are means  SD from th
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bottom. They were then reduced by dithiothreitol, alkylated with
iodoacetamide and digested with trypsin (Promega, Madison, USA) as
described in Ref. [40,41]. Liquid chromatographyeMS/MS analysis of
the extracted peptide mixtures was carried out on a hybrid linear trap
LTQ-Orbitrap XL (Thermo Scientiﬁc, Waltham, USA) mass spectrom-
eter interfaced to a nanocapillary HPLC equipped with a C18 reversed-
phase column (Thermo Scientiﬁc). Collection of tandem mass spectra
for database searching were generated from raw data with Mascot
Distiller and searched using Mascot 2.4.1 (Matrix Science, London,
UK) against the release 2012_11 of the SwissProt database (www.
uniprot.org) restricted to Mus musculus taxonomy. Mascot was
searched with a fragment ion mass tolerance of 0.50 Da and a parent
ion tolerance of 10 ppm, allowing two missed cleavages. Iodoace-
tamide derivative of cysteine was speciﬁed as a ﬁxed modiﬁcation.
Protein N-term acetylation, deamidation of asparagine and glutamine,
and oxidation of methionine were speciﬁed as variable modiﬁcations.
The software Scaffold (version Scaffold_4.1.1, Proteome Software
Inc.) was used to validate MS/MS based peptide (minimum 90%phorylation of Bim and JNK. (A) bTC-tet cells were transfected with siCT or siClic4. After
cated proteins was evaluated by western blot analysis. Densitometry analysis of protein
ree independent experiments. *p < 0.05; **p < 0.01.
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Original articleprobability [42], with delta-mass correction) and protein (min. 95%
probability [43]) identiﬁcations. Dataset alignment as well as parsi-
mony analysis to discriminate homologous hits was carried out by
Scaffold. Proteins sharing signiﬁcant peptide evidence were grouped
into clusters.
2.13. Glucose stimulated insulin secretion (GSIS)
bTC-tet cells or Min6(B1) were transfected with siCT or siClic4.
72 h later, they were washed with PBS and pre-incubated for 2 h in
KRBH-BSA (Krebs-Ringer bicarbonate HEPES buffer containing
120 mM NaCl, 4 mM KH2PO4, 20 mM HEPES, 1 mM MgCl2, 1 mM
CaCl2, 5 mM NaHCO3, and 0.5% BSA, pH7.4) supplemented with
2 mM glucose, later the medium was replaced with fresh KRBH-BSA
containing 2 or 20 mM glucose and incubated for 1 h in the pres-
ence or absence of 100 nM Exendin-4. Secreted and cellular insulin
were assessed by radioimmunoassay (RIA) using RIA kit (Millipore, MA,
USA) following manufacturer’s instructions.
2.14. Study approval
All breeding and cohort maintenance were performed in the UNIL
animal facility, and all the experiments were approved by the Service
Vétérinaire du Canton de Vaud, Switzerland.
2.15. Statistical analysis
The results are expressed as the means  S.D. Comparisons were
performed using unpaired Student’s t test or one-way analysis of
variance for the different groups followed by posthoc pairwise
multiple-comparison procedures with the Tukey test. Single, double,
and triple asterisks indicate statistically signiﬁcant differences
(*p < 0.05; **p < 0.01; ***p < 0.001).Figure 4: Clic4 silencing increases the half-lives of Bcl-2 and Bad. (A) bTC-tet cells were
cycloheximide for the indicated periods of time, and Bcl-2 and Bad expression was quanti
expression data were plotted on a logarithmic scale. The protein half-lives (t1/2) were calcu
experiments.
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3.1. Clic4 expression is induced by cytokines and its silencing
protects against apoptosis
We ﬁrst investigated whether Clic4 protein expression in bTC-tet cells
and primary mouse islets was increased by cytokines treatment.
Figure 1A,B, shows that a 15 h treatment with Il-1b, TNFa and IFNg
increased Clic4 protein expression byw30% in bTC-tet cells and by
w100% in primary mouse islets (Figure 1C,D).
To assess the effect of Clic4 silencing on cytokines-induced apoptosis,
we transfected bTC-tet cells with a control or a Clic4-speciﬁc siRNA
and assessed cytokine-induced apoptosis, in the presence or absence
of 100 nM exendin-4 added 9 h prior to the addition of cytokines.
Figure 1F shows an w3-fold increase in apoptosis upon cytokine
treatment in siCT-transfected cells and a complete protection against
apoptosis by exendin-4. Upon Clic4 silencing, the basal rate of
apoptosis was reduced by 50% as compared to siCT-transfected cells
and cytokines increased apoptosis by 2-fold, to a level that was still
w3-fold lower than in siCT-transfected cells; exendin-4 still signiﬁ-
cantly reduced cytokine-induced apoptosis. The extent of siRNA-
mediated Clic4 silencing is shown by western blot analysis in
Figure 1E.
We also assessed apoptosis by measuring caspase-3 cleavage by
western blot analysis. Figure 1G,H shows that cytokine-induced cas-
pase-3 cleavage was reduced by w50% in the siClic4-transfected
cells as compared with siCT-transfected cells and this cleavage was
still signiﬁcantly reduced by exendin-4.
Collectively, these data showed that Clic4 expression is induced by
cytokines and sensitizes bTC-tet cells to cytokine-induced apoptosis.
In addition, the anti-apoptotic effect of GLP-1 is still present upon Clic4transfected with siCT or siClic4. 48 h later they were left untreated or were treated with
tated by western blot analysis. (B, C) Densitometry analysis of the Bcl2 (B) and Bad (C)
lated by regression analysis (inset). The data are means  SD from three independent
his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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silencing indicating that GLP-1 signaling is independent of Clic4
expression.
To determine whether Clic4 is required for the normal control of
glucose-stimulated insulin secretion, we silenced Clic4 in bTC-tet cells
and in Min6B1 cells and exposed the cells to 2 or 20 mM glucose and
in the presence and absence of exendin-4. As shown in Figure 1I,J
Clic4 silencing did not impact glucose stimulated insulin secretion.
3.2. Clic4 silencing increases Bcl-2 and Bad expression as well as
Bad phosphorylation
Cytokines induce b-cell apoptosis mainly through activation of the
mitochondrial apoptotic pathway, which involves the participation of
anti- and pro-apoptotic Bcl2-family proteins [17]. We thus examined
whether Clic4 silencing would modulate expression of Bcl-2, Bcl-xL
and Bad. Here, siCT- or siClic4-transfected bTC-tet cells were treated
or not with cytokines for 15 h. Quantitative RT-PCR analysis showed no
difference in Bcl2, Bad and Bcl-xL mRNA expression in siCT or siClic4
transfected cells and no change in response to cytokine treatmentFigure 5: Generation of bClic4KO mice and resistance to apoptosis of bClic4KO b-cells. (A
of the Clic4ﬂox allele; bottom: structure of the Clic4D allele after InsCre-mediated recombin
Quantitative RT-PCR analysis of Clic4 expression in islets from bClic4KO or control mice.
dishes for 6 days to form monolayers. (D) Cells were then left untreated or pre-incubated
were left untreated or treated with 1 mM palmitic acid (PA) with or without 100 nM exen
expressed as percentage of TUNEL-positive cells over total DAPI positive cells. The data
***p < 0.001.
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showed that silencing Clic4 increased expression of Bcl-2 (w2-fold),
Bad (w1.4 fold), of phosphorylated Bad (pBad) (w2 fold), and of the
pBad/Bad ratio (Figure 2BeE). Clic4 silencing did not affect Bcl-xL
protein expression under basal conditions or after cytokine treatment
(Figure 2F) and only slightly decreased Bax protein expression after
cytokine treatment (Figure 2G).
3.3. Clic4 silencing did not affect expression of PUMA, Bims, BimL,
BimxL and phosphorylation of Bim and JNK in bTC-tet cells
We next examined expression of the pro-apoptotic members of the Bcl-
2 family, PUMA and Bim. It has been shown that JNK-induced Bim
phosphorylation on serine 65 contributes to b-cell apoptosis [44].
Moreover Bim has three main isoforms generated by alternative
splicing, namely BimEL, BimL and the most pro-apoptotic variant Bims
[45]. Hence we examined protein expression of all three variants of
Bim, phosphorylated Bim, JNK activation and PUMA in siCT- or siClic4-
transfected bTC-tet cells treated or not with cytokines for 15 h. The) Top: structure of the wild type Clic4 allele and of the targeting vector; middle: structure
ation. (B) PCR analysis of Clic4 recombination using the P1 and P2 primers (see A). (C)
(D, E) Islets from Control or bClic4KO mice were plated on extracellular matrix-coated
with 100 nM exendin-4 (Ex4) for 9 h and then treated with cytokines for 15 h. (E) Cells
din-4 (Ex-4) for 48 h. In (D) and (E), apoptosis was measured by TUNEL assay and is
are the means  SD from three independent experiments. *p < 0.05; **p < 0.01;
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Original articlewestern blot of Figure 3A-G, shows that Clic4 silencing did not affect
the expression level of PUMA, the three variants of Bim, or the
phosphorylation state of JNK or Bim.
Thus, Clic4 silencing reduces cytokines-induced apoptosis was
correlated with increased expression of the anti-apoptotic proteins Bcl-
2, Bad, and increased phosphorylation of Bad (Figure 2).
3.4. Clic4 knockdown increases the half-life of Bcl-2 and Bad
To determine whether Clic4 silencing could increase Bcl-2 and Bad
stability, siCT- or siClic4-transfected bTC-tet cells were treated with
cycloheximide for different periods of time and the level of expres-
sion of both proteins was assessed by western blot analysis. The
rate of protein degradation was expressed as log of the percentage
of initial value at t ¼ 0 and protein half-life (t1/2) was measured by
regression analysis. Clic4 silencing increased Blc2 and Bad half-lives
(Figure 4AeC) from w29 h to w66 h for Bcl2, and from w16 h to
w28 h for Bad.Figure 6: Increased expression of Bcl-2, Bcl-xL, Bad and pBad in islets from bClic4KO
cytokines for 15 h and expression levels of Clic4, Bcl-2, Bcl-xL and Bad mRNAs were asses
relative to the levels found in non-treated control islets. (E) Western blot analysis of the ind
(FeJ) Densitometry analysis of the proteins normalized to b-actin and of the ratio of pB
**p < 0.01; ***p < 0.001.
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(bClic4KO) mice
To study the role of Clic4 in primary b-cells, we generated mice with
b-cell-speciﬁc inactivation of Clic4. Figure 5A shows the recombina-
tion strategy in which exon 2 of the Clic4 gene was ﬂanked by loxP
sites by homologous recombination in embryonic stem cells. Clic4lox/lox
mice were crossed with Ins1Cre mice [38], which ensure complete and
b-cell-selective ﬂoxed gene recombination, in order to obtain Clic4 lox/
lox;Ins1Cre/þ (bClic4KO) and Clic4 lox/lox;Ins1þ/þ (Control) mice. Se-
lective recombination in the islets was conﬁrmed by PCR analysis of
recombined alleles (Figure 5B); this led to w85% reduction in Clic4
gene expression in bClic4KO mouse islets (Figure 5C), consistent with
Clic4 inactivation in all b-cells.
To assess whether inactivation of Clic4 in b-cells would impact
glucose homeostasis, we generated cohorts of male and female
control and bClic4KO mice and fed them a normal chow for 18 weeks,
or a high fat diet for 12 weeks starting at 6 weeks of age. No differencemice. (AeD) Islets from bClic4KO or control mice were left untreated or treated with
sed by qRT-PCR; expression levels were normalized to tbp mRNA levels and expressed
icated proteins in the islets of control and bClic4KO mice treated or not with cytokines.
ad/Bad. The data are means  SD from three independent experiments. *p < 0.05;
his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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in glucose tolerance nor in insulin secretion could be observed be-
tween Control and bClic4KO mice following intraperitoneal glucose
injections, nor any difference in b-cell mass (not shown).
3.6. Islet b-cells from bClic4KO mice are less sensitive to induced
apoptosis
Islets from control and bClic4KO mice were cultured on extracellular-
coated Petri dishes to induce monolayer formation. Cells were then
exposed to cytokines for 15 h with or without a 9 h pretreatment with
exendin-4. Apoptosis was then measured by TUNEL assay. Figure 5D
shows that cytokines induced apoptosis inw7% of control islet cells
and w4% of bClic4KO islets. Exendin-4 signiﬁcantly reduced
cytokine-induced apoptosis in both types of islets. Similarly, palmitic
acid-induced apoptosis was lower in bClic4KO b-cells and exendin-4
also reduced apoptosis in both types of islets (Figure 5E). Thus, Clic4 is
also a pro-apoptotic protein in primary islet cells. Note that we did not
speciﬁcally measure apoptosis in b-cells but rather in the whole islet
cell population, but the use of Ins1Cre mice ensures that Clic4 is
inactivated only in b-cells [38].
3.7. Islets from bClic4KO mice have increased expression of Bcl2,
Bcl-xL, Bad, and pBad
We next evaluated Bcl-2, Bad and Bcl-xL mRNA expression in islets
from bClic4KO and control mice exposed or not to cytokines for 15 h.
Figure 6A shows that Clic4 mRNA expression was increased byw9-
fold after cytokine treatment in control islets; Bcl-2 mRNA expression
was increased by 50% in islets from bClic4KO mice in the absence of
treatment but was not different after cytokine treatment (Figure 6B);
Bad mRNA expression was increased by w30% in islets from
bClic4KO mice under basal conditions and following cytokines treat-
ment (Figure 6C) and Bcl-xL mRNA level was not signiﬁcantly different
in islets from bClic4KO or control mice under basal conditions or
following cytokine treatment (Figure 6D).Figure 7: Mass-spectrometry analysis of proteins associated with Clic4. (A) Clic4 was im
Clic4 antibodies; rabbit IgGs were used as a negative immunoprecipitation control. The imm
with Bcl2 and Bad, which was negative. (B) The immunoprecipipates of (A) were also subje
regions, digested with trypsin and analyzed by mass spectrometry analysis for analysis o
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or not with cytokines for 15 h, showed anw2-fold increased expression
of Bcl-2 in the islets from bClic4KO mice as compared to control islets,
both in the presence or absence of cytokines. Total Bad expression and
the level of phosphorylated Bad were also increased in bClic4KOmouse
islets and the ratio of pBad to total Bad was increased by w75% in
basal conditions andw60% after cytokines treatment (Figure 6H). Bcl-
xL expression was higher byw77% in islets from bClic4KO mice as
compared with islet from control mice; this difference no longer reached
signiﬁcance after cytokine treatment (Figure 6J).
3.8. Mass-spectrometry analysis of proteins associated with Clic4
Because the above data indicated higher level and stability of Bcl2, Bad
and pBad in the absence of Clic4, we wondered whether this could be
due to the suppression of a direct interaction of Clic4 with these
proteins. We therefore immunoprecipitated Clic4 from bTC-tet cells
using antibodies directed against the C- or N-terminal ends of the
protein and subjected the immunoprecipitates to western blot and LCe
MS/MS analysis. Figure 7A shows that Clic4 antibodies efﬁciently
immunoprecipitated Clic4 and that neither Bcl2 nor Bad co-
immunoprecipitated with Clic4. The co-immunoprecipitates were
then separated by gel electrophoresis (Figure 7B) and the individual
lanes were cut in small segments for trypsin digestion and mass
spectrometry analysis. We identiﬁed 78 proteins that were selectively
enriched in the Clic4 co-immunoprecipitates as compared with the
control IgG co-immunoprecipitate. Sixty-six proteins were co-
immunoprecipitated with the C-terminal antibody, 10 with the N-ter-
minal antibody, and two with both antibodies (Table 1). The proteins
were grouped according to their biological or cellular functions
(Table 1), showing that they pertain to diverse cellular processes such
as proteasomal degradation, protein biosynthesis, cell cycle, kinase/
phosphatases, apoptosis, protein transport and regulator of GTPase
activity.munoprecipitated from 1 mg of bTC-tet cell lysate proteins using the C- or N-terminal
unoprecipitated proteins were analyzed by western blotting for co-immunoprecipitation
cted to SDS-PAGE followed by Coomassie blue staining. Each gel lanes was cut into six
f proteins speciﬁcally associated with Clic4 (see Table 1).
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Table 1 e List of Clic4-binding proteins identiﬁed by mass-spectrometry. Proteins co-immunoprecipitated with Clic4 from bTC-tet cells (Figure 7) were
identiﬁed by mass spectrometry. Most of the proteins were pulled-down with the C-terminal antibody. *Indicates the proteins pulled-down with the N-terminal
antibody and ** indicates those pulled-down with both C- and N-terminal antibodies.
List of Clic4-binding proteins
Proteins involved in protein biosynthesis Proteins involved in cell cycle
1 Ile-tRNA synthetase 46 DNA replication licensing factor MCM2
2 Arg-tRNA synthetase 47 Replication factor C subunit 5
3 Met-tRNA synthetase 48 Chromosome transmission ﬁdelity protein 18 homolog
4 Leu-tRNA synthetase 49 Paired amphipathic helix protein Sin3a
5 Asp-tRNA synthetase 50 CD2-associated protein
6 Lys-tRNA synthetase 51 Sister chromatid cohesion protein DCC1
7 Ala-tRNA synthetase 52* Proliferating cell nuclear antigen
8 Thr-tRNA synthetase 53 Centrosomal protein of 89 kDa
9 Glu-Pro-tRNA synthetase 54 Kinetochore-associated protein NSL1 homolog
10 AIMP1/p43 55 Kinetochore-associated protein DSN1 homolog
11 AIMP2/p38 56 Polyamine-modulated factor 1
12 AIMP3/p18 57 Protein CASC5
13e17 eIF3 subunit B, A, H, M, E 58* NIF3-like protein 1
18** 40S ribosomal protein S9 59* Cyclin-G-associated kinase
19** 60S ribosomal protein L17 Kinases/Phosphatases
Proteins involved in apoptosis 60-61 cAMP-dependent protein kinase type I-alpha and type II-alpha.
10 AIMP1/p43 62* Serine/threonine-protein kinase MRCK beta
11 AIMP2/p38 63* Protein phosphatase 1 regulatory subunit 12A
12 AIMP3/p18 64* Myotubularin-related protein 5
Proteins involved in protein degradation 65* Serine/threonine-protein phosphatase PP1-beta catalytic subunit
20e26 26S proteasome non-ATPase regulatory subunit 2, 1, 11, 13, 6, 7, 5. 66 Type II inositol 1,4,5-trisphosphate 5-phosphatase
27e31 26S protease regulatory subunit 8, 6B, 7, 10B, 4. Proteins involved in GTPase activity
32 F-box only protein 28 67 Arf-GAP
33 DNA damage-binding protein 1 68 RhoGEF (Factor 12 and 1)
Proteins transport 69 Dedicator of cytokinesis protein 7
34 Kinesin-1 heavy chain 70 SH3 domain-binding protein 1
35e37 Kinesin light chain 1, 2 and 4 71* Neuroﬁbromin
38 Kinesin-like protein KIF11 72* BTB/POZ domain-containing protein KCTD12
39 14-3-3 protein epsilon 73* GTPase-activating protein and VPS9 domain-containing protein 1
40 Torsin-1A-interacting protein 1 74* Jouberin
41 AP-3 complex subunit beta-1 Others
42* Membrane-associated phosphatidylinositol transfer protein 1 43* SUN domain-containing protein 2
75 Spectrin beta chain 76 Spectrin alpha chain
44 Myomegalin 77 F-actin-capping protein subunit beta
Proteins involved in cell cycle 78* 3-hydroxyisobutyrate dehydrogenase, mitochondrial
45 DNA replication licensing factor MCM3
Unmarked, protein pull-down with C-ter Ab; *, protein pull-down with N-ter Ab; **, protein pull down by both C- and N-ter Ab.
Original article4. DISCUSSION
The present study shows that Clic4 is a cytokine-induced gene in
pancreatic b-cells, and that silencing its expression in bTC-tet cells or
inactivating its gene in primary b-cells markedly reduces cytokines-
induced apoptosis. b-cells from bClic4KO mice were also more
resistant to lipotoxicity, suggesting a role for Clic4 also in ER-stress
mediated apoptosis. Suppressing Clic4 expression leads to
increased stability of Bcl-2 and Bad and increased levels of pBad.
Liquid chromatographyeMS/MS analysis revealed that Clic4 does not
directly interact with Bcl2 family proteins, while it interacts with
components of the proteasome and other protein classes. Thus, Clic4
is a newly described b-cell pro-apoptotic gene that regulates the half-
lives of Bcl-2 family proteins through an indirect mechanism, possibly
involving proteasome action.
Cytokines induce b-cell apoptosis mainly through activation of the
mitochondrial apoptotic pathway, which involves regulated expression
of anti- and pro-apoptotic Bcl2-family proteins and their differential
interactions eventually leading to induction of mitochondrial perme-
ability, cytochrome c release, and activation of caspase 3 [17]. Here,
we showed that Clic4 knockdown in bTC-tet cells or genetic262 MOLECULAR METABOLISM 4 (2015) 253e264  2015 The Authors. Published by Elsevier GmbH. Tinactivation in islets b-cells increased expression of the anti-apoptotic
proteins Bcl-2, Bcl-xL, and led to increased phosphorylation of Bad,
which inhibits its pro-apoptotic activity. Increased expression of these
proteins was independent from changes in their mRNA levels, indi-
cating a regulation at the translational or posttranslational level.
Analysis of protein stability showed that the half-lives of Bcl-2 and Bad
were indeed markedly prolonged in the absence of Clic4. Mass
spectrometry analysis of the Clic4-interacting proteins did not reveal
any interactions with Bcl2 family proteins suggesting that Clic4 has an
indirect role on Bcl2 and Bad stability. This analysis, however, revealed
interactions of Clic4 with several proteins involved in proteosomal
degradation, suggesting that Clic4 may regulate the rate of Bcl2 family
proteins degradation through proteasomal activity. We attempted to
determine whether blocking proteasomal activity with a speciﬁc in-
hibitor, MG132, would impact the stability of Bcl2 or Bad in the
presence or absence of Clic4. However, MG132 treatment was toxic for
bTC-tet cells leading to their death already 12 h after beginning of the
treatment. This prevented analysis of the impact of blocking protea-
some activity on Bcl-2 and Bad because their half-lives are greater
than 20 h. Whether absence of Clic4 has a role in the control of Bad
and Bcl2 biosynthesis is not yet known.his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Clic4 also sensitizes b-cells to palmitic-acid induced apoptosis, a
process associated with increased expression of ER stress markers
[46,47]. In bTC-tet cells, thapsigargin-induced ER stress increased the
expression of the ER stress markers genes Chop, Atf4, Gadd34, Atf6,
Bip, and the spliced form of Xbp1 to the same extent in control or Clic4-
silenced cells (data not shown). Thus, the protection against lipotoxicity
conferred by Clic4 silencing is unlikely due to repression of ER stress
markers but may depend on the increased stability of Bcl-2, Bcl-xL and
pBad.
Mass spectrometry analysis of Clic4 immunoprecipitates revealed that
Clic4 binds to proteins involved in several cellular process or functions,
including protein biosynthesis, cell-cycle, apoptosis, protein degra-
dation, protein transport, and kinases or phosphatases. These data
suggest that Clic4 may affect cell survival through different mecha-
nisms, possibly in a context dependent manner.
Finally, CLIC4 is also well expressed in human islets (Median RPKM 23,
RNASeq data [48]), and there is a 1.7-fold increase in its expression
following a 48 h exposure to cytokines while there is no clear change in
expression following 48 h palmitate exposure (Median RPKM 26; n¼ 5
[49]). CLIC4 is also well expressed in FACS-puriﬁed rat beta cells, with
a 5e7-fold increase in expression after 6 or 24 h exposure to IL-
1 þ IFNg or TNF þ IFNg [50]. It is conceivable that we did not see a
more marked increase in CLIC4 expression human islets due to the late
time of study.
Collectively, our data show that Clic4 sensitizes b-cells to cytokines- or
palmitic acid-induced apoptosis. Reducing Clic4 expression increases
b-cell survival, an event associated with, and likely caused by, the
increased stability and cellular expression levels of Bcl-2, Bcl-xL and of
the phosphorylated form of Bad. It is indeed known that Bcl-2 or Bcl-xL
overexpression in b-cells increases their resistance to cytokine-
induced apoptosis [51e53]. Thus, targeting Clic4 expression or its
interaction with speciﬁc protein partners identiﬁed in our mass
spectrometry analysis may provide a new way to prevent b-cell
apoptosis in the context of diabetes mellitus.
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